baber/WOPTO huggingface dataset:
Patent AU-4796190-A (AU)
Title: Benzonaphthalene derivatives, a process for their preparation and their use in therapeutic and cosmetic compositions
Inventor: SHROOT BRAHAM
IPC: C07C/
Filed: 1990-01-15
Abstract: A benzonaphthalene compound has the formula    <IMAGE>  (I)  wherein R1 represents   <IMAGE>   or (ii) -CH2OH; R6 represents   <IMAGE>   or OR7 wherein R7 represents hydrogen, alkyl having 1-20 carbon atoms, monohydroxyalkyl or polyhydroxyalkyl, r' or r'' represent hydrogen, lower alkyl, mono or polyhydroxyalkyl, aryl or a residue of an amino acid or a sugar, or together form a heterocycle; R2 represents hydrogen, alkyl having 1-15 carbon atoms, alkoxy having 1-4 carbon atoms or a cycloaliphatic radical; R3 represents hydrogen, hydroxy, alkyl having 1-4 carbon atoms, alkoxy having 1-10 carbon atoms, a cycloaliphatic radical, a thiocycloaliphatic radical or -O-Si(CH3)2-R8 wherein R8 represents lower alkyl; and R4 and R5 represent hydrogen, lower alkyl, hydroxy or lower acyloxy. This compound is useful in the topical and systemic treatment of dermatologic diseases and in the treatment of the degeneration of conjunctive tissues. The compound also possesses anti-tumor acitivity.
Patent AU-4907690-A (AU)
Title: Preparation of tris(2-aminoethyl)amine
Inventor: O'NEILL GERALD J
IPC: C07C209/48
Filed: 1990-02-05
Abstract: Polyamines are prepared via the batchwise hydrogenation of polynitriles by the gradual addition of the polynitrile into a fed-batch reactor which contains a Raney cobalt catalyst. The hydrogenation is optionally conducted in the presence of anhydrous ammonia. The polyamine is economically obtained in high selectivity and yield.
Patent AU-5168693-A (AU)
Title: Estrene steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
Inventor: BERLINER DAVID L
IPC: A61K31/56
Filed: 1993-09-28
Abstract: The invention relates to a method of altering hypothalamic function in an individual. The method comprises nasally administering a human semiochemical, e.g. an Estrene steroid, or a pharmaceutical composition containing an Estrene steroid, such that the ligand semiochemical binds to a specific neuroepithelial receptor. The steroid is preferably administered in the form of a pharmaceutical composition containing one or more pharmaceutically acceptable carriers. Other embodiments of the invention include pharmaceutical compositions containing the steroids.
Patent AU-5341396-A (AU)
Title: A shaft seal
Inventor: AUBER PHILIPPE JACQUES
IPC: F16J15/34
Filed: 1996-04-22
Abstract: The present invention relates to a shaft seal (1) comprising a sealing element (14) mounted co-axially to a rotary sealing ring (10) to form a primary seal between opposed faces thereof to substantially prevent fluid flow across the primary seal. The sealing element (14) is urged axially towards the rotary ring (10) by a springs (15) acting between a pusher sleeve (15) connected to the sealing element 14 and a seal housing (19). A secondary seal formed between the pusher sleeve (15) and the housing (19) by a sealing member (20) located in a channel (21) in the pusher sleeve (15).
Patent AU-5421496-A (AU)
Title: Nonpeptides as tachykinin antagonists
Inventor: HORWELL DAVID CHRISTOPHER
IPC: C07C271/34
Filed: 1996-03-12
Abstract: The small nonpeptides of the instant invention are tachykinin antagonists. The compounds are highly selective and functional NK3 antagonists expected to be useful in the treatment of pain, depression, anxiety, panic, schizophrenia, neuralgia, addiction disorders, inflammatory diseases, gastrointestinal disorders, vascular disorders, and neuropathological disorders.
Patent AU-5485194-A (AU)
Title: Hydrogel bandages
Inventor: PARTYKA DORIS
IPC: A61L15/60
Filed: 1994-02-01
Abstract: A hydrogel dressing is provided which is suitable for adherence to an adhesive coated backing of a bandage. The dressing consists of a layer of hydrogel in face-to-face relationship with a substrate. The hydrogel facing surface of the substrate preferably comprises fibers projecting into the hydrogel and the opposed surface preferably comprises a hydrogel occlusive polymeric film. The hydrogel is crosslinked, in situ, on the substrate and thereby firmly anchors thereto. The occlusive film assures adhesion of the dressing to an adhesive coated bandage backing.
Patent AU-5517694-A (AU)
Title: Collating apparatus
Inventor: VERNON GEOFFREY WILLIAM
IPC: B65H31/30
Filed: 1994-02-17
Abstract: Collating apparatus for collecting and handling stacks of generally flat articles (T) comprises a chute (40) in which the successive stacks are collected. Each completed stack is expelled from the chute by pusher means (52) into a carriage (58) of transfer device (54). The transfer device has mounted on a rotary axis (56) inclined at 45 DEG . Each rotation of the transfer device brings one carriage to a vertical position to receive the completed stack from the chute and brings the stack previously loaded into the other carriage to a horizontal position over a carton (C) into which the stack is to be deposited. <IMAGE>
Patent AU-5646890-A (AU)
Title: Autoantibodies which enhance the rate of a chemical reaction
Inventor: SUDHIR PAUL
IPC: A61P35/00
Filed: 1990-04-25
Abstract: Autoantibodies which enhance the rate of a chemical reaction of a substrate, processes for their preparation, their use and compositions thereof are disclosed. In particular, an autoantibody capable of catalyzing the hydrolysis of the peptide bond between amino acid residues 16 and 17 in the neurotransmitter vasoactive intestinal peptide (VIP) is disclosed.
Patent AU-5730686-A (AU)
Title: A method and an arrangement for minimising the magnetizing current passing through a transformer
IPC: H01F27/42
Filed: 1986-05-09
Abstract: The invention relates to a method and to an arrangement for controlling the respective conduction times of two directionally opposed electrical devices (9, 10) which are mutually connected in parallel and permit current to pass therethrough solely in one direction, and which also permit current (l<sub>2</sub>) to pass through the primary winding (2) of a transformer during a respective half-period of an A.C. voltage (U,) applied to the primary winding, this control being effected so that the magnetizing current through the transformer can be advantageously minimized and/or held beneath a given limit value when an asymmetric load (4, 5) is applied to the secondary side (3) of the transformer. A magnetizing current in the primary winding corresponding to the load (5) of the secondary winding (3) is controlled through the agency of different conduction times of the two directionally opposed devices (9, 10).
Patent AU-5789300-A (AU)
Title: Time of arrival based positioning during handover
Inventor: HUSSAIN TAHIR
IPC: H04W64/00
Filed: 2000-07-07
Abstract: A telecommunications system and method is disclosed for allowing an ongoing Time of Arrival (TOA) based positioning of a mobile station to proceed if a radio related handover has occurred before the expiration of a delta timer in a Base Station Controller (BSC). The BSC stores an HOTIMER value therein, which corresponds to the amount of time involved in a normal radio-related handover procedure from the sending of a Handover Command to the reception of a Handover Complete message. If the BSC delta timer is active, e.g., positioning is ongoing, and the BSC determines that a radio related handover is needed, the BSC checks the amount of time remaining in the BSC delta timer. If that amount is more than the HOTIMER, then the ongoing positioning is not canceled.
Patent AU-5857986-A (AU)
Title: Apparatus for temperature measurement in a converter
Inventor: MEININGHAUS FRITZ
IPC: G01J5/00
Filed: 1986-06-12
Abstract: 1. Device for measuring the temperature in a converter with a radiation measuring instrument (17), which is connected to one end of a rectilinear channel (14) to receive the radiation propagated through the channel, whereas the other end of the channel opens out into the liquid molten steel and an inert gas or a low reaction gas or gas mixture at excess pressure flows into the molten steel at this end, characterised in that the channel (14) has a cross sectional area that is not greater than 1 cm**2 at least at the end terminating at the molten steel and the discharge velocity of the gas or gas mixture is large enough to produce a flow of at least 10 gram per minute with repect to a cross section of 1 mm**2 and that a temperature radiation measuring instrument (17) is connected to the channel as radiation measuring instrument.
Patent AU-6028599-A (AU)
Title: Methods of treating hypertension and compositions for use therein
Inventor: SCHREINER GEORGE F
IPC: G01N33/50
Filed: 1999-09-09
Abstract: The present invention provides methods and compositions of treating hypertension. The methods generally involve administering a factor which increases angiogenesis and/or vascular permeability. Compositions for use in the methods are also provided.
Patent AU-6029286-A (AU)
Title: A growth-stimulating animal feed, a process for preparing it, and an additive to be used in it
IPC: A23L27/30
Filed: 1986-07-17
Abstract: The invention provides a lactitol-containing feed which stimulates the growth of monogastric domestic animals, especially calves.
Patent AU-6097096-A (AU)
Title: Process for the synthesis of benzo{b}thiophenes
Inventor: HOARD DAVID W
IPC: C07D333/56
Filed: 1996-06-04
Abstract: The present invention is directed to a new process for the synthesis of 2-aryl benzo[b]thiophenes, and to novel intermediates therefor.
Patent AU-6269600-A (AU)
Title: Protecting laminate for automotive carpeting
Inventor: THELE BERNHARD
IPC: B60N3/04
Filed: 2000-07-06
Abstract: Another object of the present invention is therefore a process for the preparation of a carpet comprising an upper fibrous layer, an intermediate thermoplastic protective laminate and a polyurethane foam layer wherein the polyurethane foam layer is formed on the surface of the protective laminate which is hot bonded to the upper fibrous layer characterized in that said protective laminate comprises a first outer layer which is facing the upper fibrous layer comprising an ethylene homo- or copolymer, a core layer comprising a polyamide and a second outer layer comprising a thermoplastic polyurethane.
Patent AU-6501180-A (AU)
Title: Hybrid cell hire for producing monoclonal antibody
Inventor: KUNG P C S
IPC: C12N15/00
Filed: 1980-12-03
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on normal human suppressor T cells. The hybrid is formed by fusing splenocytes from immunized CAF<sub>1</sub> mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Patent AU-6640496-A (AU)
Title: Biguanide composition and method for treating water
Inventor: UNHOCH MICHAEL J
IPC: A01N25/30
Filed: 1996-07-29
Abstract: A water treatment method for controlling the growth of algae, fungi and bacteria and the formation of a waterline residue in recreational and industrial water supplies containing turbulent water utilizes a composition containing a polyhexamethylene biguanide compound and a surfactant. The water treatment method and composition containing the biguanide compound and surfactant are particularly useful for treating recreational water supplies like spas and swimming pools containing turbulent water, such as aerated water.
Patent AU-6678196-A (AU)
Title: Hetero-telechelic polymers and processes for making same
Inventor: SCHWINDEMAN JAMES S
IPC: C08F4/48
Filed: 1996-07-19
Abstract: Hetero-telechelic polymers having the formula:wherein FG is a protected or non-protected functional group; Q is a saturated or unsaturated hydrocarbyl group derived by incorporation of a compound selected from the group consisting of conjugated diene hydrocarbons, alkenylsubstituted aromatic hydrocarbons, and mixtures thereof; d is an integer from 10 to 200; Z is a branched or straight chain hydrocarbon group which contains 3-25 carbon atoms, optionally containing aryl or substituted aryl groups; J is oxygen, sulfur, or nitrogen; [A(R<1>R<2>R<3>)]x is a protecting group, wherein A is an element selected from Group IVa of the Periodic Table of Elements; R<1>, R<2>, and R<3 >are each independently selected from the group consisting of hydrogen, alkyl, substituted alkyl groups containing lower alkyl, lower alkylthio, and lower dialkylamino groups, aryl or substituted aryl groups containing lower alkyl, lower alkylthio, and lower dialkylamino groups, and cycloalkyl and substituted cycloalkyl containing 5 to 12 carbon atoms; and x is dependent on the valence of J and varies from one when J is oxygen or sulfur to two when J is nitrogen, with the proviso J and FG are not the same, and processes for making the same.
Patent AU-6698994-A (AU)
Title: Refastenable mechanical fastening system attached to substrate protrusion
Inventor: THOMAS DENNIS ALBERT
IPC: B29D5/00
Filed: 1994-03-30
Abstract: The invention is a refastenable mechanical fastening system, made of free-formed prongs joined to an embassey or raised substrate. The prongs taper and are nonperendicularly oriented relative to the plane of the substrate. Each prong has an engaging element projecting laterally from the periphery of the prong. The free formed prongs are manufactured by the process of depositing liquid material onto the embossed or raised portion of a moving substrate, stretching the liquid material in a direction parallel to the plane of the embossed or raised substrate and severing the stretched material to form the distal end and engaging element of the prong. The advantageous usage of the fastening system in an article of manufacture, such as a disposable absorbent garment, specifically a diaper, is also disclosed.
Patent AU-6755990-A (AU)
Title: Method of producing active immunity against a viral disease
Inventor: WHITFILL CRAIG E
IPC: A61P37/04
Filed: 1990-10-01
Abstract: A method of producing active immunity against a viral disease in an animal subject comprises administering to the subject a vaccine conjugate consisting essentially of a live virus and a neutralizing factor bound to the live virus. The neutralizing factor is selected from the group consisting of antibodies and antibody fragments. The live virus is one capable of producing disease in the subject, and the antibody or antibody fragment is one capable of neutralizing the live virus. <IMAGE>
Patent AU-6829500-A (AU)
Title: Method for the continuous production of methyl formiate
Inventor: AUER HEINZ
IPC: C07C29/80
Filed: 2000-07-26
Abstract: A description is given of a process for preparing methyl formate by reacting excess methanol with carbon monoxide under superatmospheric pressure and at elevated temperature in the presence of alkali metal methoxide or alkaline earth metal methoxide as catalyst in a pressure-rated reactor, in which the use of at least two reactor elements, preferably operated in countercurrent, at about 100° C. and a pressure of about 100 bar in combination with a solids-free desalting of the reaction product makes possible very economical, largely trouble-free production of methyl formate in any desired quality and with a very good production capacity. Furthermore, the process for solids-free desalting and apparatuses for carrying out this process are described.
Patent AU-6835901-A (AU)
Title: Cryogenic preservation of biologically active material using high temperature freezing
Inventor: PRIEN SAMUEL D
IPC: C12N5/076
Filed: 2001-06-12
Abstract: Viable biological material is cryogenically preserved (cryopreservation) by chemically preparing the material for freezing, immersing the material in a tank of cooling fluid, and circulating the cooling fluid past the material at a substantially constant predetermined velocity and temperature to freeze the material. A method according to the present invention freezes the biologic material quickly enough to avoid the formation of ice crystals within cell structures (vitrification). The temperature of the cooling fluid is preferably between -20° C. and -30° C., which is warm enough to minimize the formation of stress fractures in cell membranes due to thermal changes. Cells frozen using a method according to the present invention have been shown to have approximately an 80 percent survival rate, which is significantly higher than other cryopreservation methods.
Patent AU-7014300-A (AU)
Title: Cathode for electrolysing aqueous solutions
Inventor: ANDOLFATTO FRANCOISE
IPC: C25B11/06
Filed: 2000-08-18
Abstract: A cathode comprising an electrically conductive substrate made of titanium, nickel, tantalum, zirconium, niobium, iron or alloys thereof, coated with an intermediate layer of oxides of titanium and of a precious metal, and with an outer layer comprising metal oxides of titanium, zirconium and a precious metal, can be used for the electrolysis of solutions, in particular for the electrolysis of aqueous solutions of alkali metal chlorides.
Patent AU-7136800-A (AU)
Title: Preparation of compounds useful for the detection of hypoxia
Inventor: DOLBIER WILLIAM R JR
IPC: C07D233/54
Filed: 2000-07-20
Abstract: Novel  18 F-fluorine compounds useful for non-invasive imaging techniques such as PET, for detecting tissue hypoxia, and methods for preparing them are disclosed. Novel intermediate compounds and methods for preparing them are also disclosed. Diagnostic kits useful in practicing the methods of claimed invention are also provided.
Patent AU-7144901-A (AU)
Title: Human papilloma virus treatment
Inventor: NEEFE JOHN
IPC: A61P31/12
Filed: 2001-06-26
Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
Patent AU-7237698-A (AU)
Title: Medicinal compositions against helicobacter pylori
Inventor: WATANABE MASATO
IPC: C07D215/60
Filed: 1998-05-14
Abstract: An anti-Helicobacter pylori pharmaceutical composition containing a 1-hydroxy-3-methyl-quinolone derivative represented by the following formula (I) <CHEM> or a pharmaceutically acceptable salt thereof as an active ingredient. Since it shows antibacterial action upon Helicobacter pylori, this invention is effective for the treatment or prevention of infection with Helicobacter pylori in human and infection with related bacteria belonging to the genus Helicobacter in animals. Also, the anti-Helicobacter pylori pharmaceutical composition of the present invention is useful for the prevention (including prevention of relapse) or treatment of diseases of the upper digestive organs, such as peptic ulcers (e.g., gastric and duodenal ulcers), inflammations (e.g., acute or chronic gastritis or duodenitis) and gastric cancer, as well as MALT (mucosa-associated lymphoid tissue) lymphoma or chronic heart diseases.
Patent AU-7414691-A (AU)
Title: New 3-aminochroman derivatives, process for preparing these and pharmaceutical compositions containing them
Inventor: GUILLAUMET GERALD
IPC: A61P25/24
Filed: 1991-04-08
Abstract: The invention relates to compounds of the formula (I):    <IMAGE>  (I)  in which: Z represents an oxygen atom or a sulfur atom, R1 represents a hydrogen atom or an alkyl group, R2 represents a hydrogen atom or an alkyl group, n is one to six, inclusive, R3 represents an amino group, substituted with phenylsulfonyl, and medicinal products containing the same.
Patent AU-7471894-A (AU)
Title: Sanitizing compositions
Inventor: RICHTER FRANCIS L
IPC: C11D7/26
Filed: 1994-07-12
Abstract: This invention is a microbicidal and tuberculocidal composition comprising a major portion of carrier and an effective sanitizing amount of octanoic acid, or octanoic acid derivatives, and a sulfur containing compound. Optionally, the invention may also comprise any variety of formulatory ingredient options or application adjuvants. The invention comprises concentrate compositions and methods of sanitizing and disinfecting using the antimicrobial composition of the invention.
Patent AU-7526996-A (AU)
Title: Tree-based certificate revocation system
Inventor: MICALI SILVIO
IPC: G06Q20/02
Filed: 1996-11-01
Abstract: A method and system for overcoming the problems associated with certificate revocation lists (CRL's), for example, in a public key infrastructure. The invention uses a tree-based scheme to replace the CRL.
Patent AU-7559196-A (AU)
Title: Clamping device for detachably connecting two profiled parts
Inventor: STRASSLE MARCEL
IPC: F16B7/04
Filed: 1996-11-26
Abstract: PCT No. PCT/CH96/00415 Sec. 371 Date May 21, 1998 Sec. 102(e) Date May 21, 1998 PCT Filed Nov. 26, 1996 PCT Pub. No. WO97/20148 PCT Pub. Date Jun. 5, 1997The invention concerns a clamping device for detachably connecting two profiled parts (1, 19). There can be inserted and secured in a first profiled part (1) an insert core (2) comprising an axially movable slide (7) with an end part having a projection (17, 18) which can be at least partially inserted into an opening in a second profiled part (19) in order to exert clamping pressure against a portion of the second profiled part (19), which portion partially closes the opening. The slide (7) is flat, and the insert core (2) comprises two inner grooves for axially guiding the slide (7). Rotatably guided in the insert core (2) is an eccentric (5). When the eccentric head (4) is rotated, the eccentric roller (22) presses against the inner wall (30) of a recess (12) in the slide (7) in order to move the latter into the insert core (2) into a position which enables the projection to exert the aforementioned clamping pressure.
Patent AU-7559694-A (AU)
Title: Monoclonal antibodies to thymidine kinase isozymes
Inventor: O'NEILL KIM L
IPC: C12P21/08
Filed: 1994-08-05
Abstract: Thymidine kinase 1 (TK1) activity in a sample is detected by contacting a monoclonal antibody to active TK1 with the sample, and determining the amount of the monoclonal antibody bound to active TK1. A method of predicting recurrence of a tumor in a patient comprises the steps of establishing a normal range for thymidine kinase 1 (TK1) activity, determining the amount of TK1 activity in a sample from a cancer patient, and comparing the value of the normal range for TK1 activity with the TK1 activity in the sample from the cancer patient, wherein when said TK1 activity from the cancer patient significantly exceeds the normal range for TK1 activity it is predicted that the tumor is likely to recur.
Patent AU-7616194-A (AU)
Title: Method for the manufacture of a mat-like product
Inventor: NIEMINEN JORMA
IPC: B27N3/02
Filed: 1994-09-09
Abstract: In a method for making a fibrous product from separate particles, an air flow (A) is used for forming a mat on an advancing forming platform (1). The particles are bonded to form the mat by means of thermally activatable binder material brought to the mat forming site such that it upon being activated through the action of heat bonds the particles to each other in the mat. Said binder material is brought to an activated state already in air flow (A) carrying the particles onto forming platform (1) by setting temperature of the air flow sufficiently high. The material forming the base of the mat in the particles is constituted of a material activatable at a higher temperature than the thermally activatable binder material.